Hypertrophic Cardiomyopathy: An Overview

  • Stephen E. Epstein
  • Barry J. Maron
Conference paper

Abstract

Hypertrophic cardiomyopathy presents extraordinary challenges to the investigator, partly because of the extreme diversity in its clinical, hemodynamic, and anatomical presentation, and partly because of the rapid changes that have occurred in our understanding of its pathophysiology, natural history, and treatment since it was first recognized as a clinical entity in 1958 [1]. The profound changes that have occurred in our concepts of the disease are reflected in Table 1, which lists the names that have been appended to this entity at one time or another over the years.

Keywords

Hypertrophic Cardiomyopathy Left Ventricular Free Wall Subaortic Stenosis Asymmetric Septal Hypertrophy Left Ventricular Outflow Tract Gradient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Teare RD (1958) Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20: 1–8PubMedCrossRefGoogle Scholar
  2. 2.
    Braunwald E, Morrow AG, Cornell WP, Aygen MM, Hillbish TF (1960) Idiopathic hypertrophic subaortic stenosis: hemodynamic and angiographic manifestations. Am J Med 29: 924–945CrossRefGoogle Scholar
  3. 3.
    Wigle ED, Heimbecker RO, Gunton RW (1962) Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26: 325–340PubMedGoogle Scholar
  4. 4.
    Cohen J, Effat H, Goodwin JF, Oakley CM, Steiner RE (1964) Hypertrophic obstructive cardiomyopathy. Br Heart J 26: 16–32PubMedCrossRefGoogle Scholar
  5. 5.
    Henry WL, Clark CE, Epstein SE (1973) Asymmetric septal hypertrophy (ASH): echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 47: 225–233PubMedGoogle Scholar
  6. 6.
    Abbasi AS, MacAlpin RN, Eber LM, Pearce ML (1972) Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 46: 897–904PubMedGoogle Scholar
  7. 7.
    Abbasi AS, MacAlpin RN, Eber LM, Pearce ML (1973) Left ventricular hypertrophy diagnosed by echocardiography. N Engl J Med 289: 118–121PubMedCrossRefGoogle Scholar
  8. 8.
    Epstein SE, Henry WL, Clark CE, Roberts WC, Maron BJ, Ferrans VJ, Redwood DR, Morrow AG (1974) Asymmetric septal hypertrophy. Ann Intern Med 81: 650–680Google Scholar
  9. 9.
    Clark CE, Henry WL, Epstein SE (1973) Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med 289: 709–714PubMedCrossRefGoogle Scholar
  10. 10.
    Van Dorp WG, Ten Cate FJ, Vletter WB, Dohmen H, Roelandt J (1976) Familial prevalence of asymmetric septal hypertrophy. Eur J Cardiol 4: 349–357PubMedGoogle Scholar
  11. 11.
    Maron BJ, Epstein SE (1979) Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 43: 1242–1244PubMedCrossRefGoogle Scholar
  12. 11a.
    Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle two-dimensional echocardiographic study of 125 patients. J Cardiol 48: 418–428CrossRefGoogle Scholar
  13. 12.
    Maron BJ, Gottdiener JS, Bonow RO, Epstein SE (1981) Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography: Identification by wide-angle two-dimensional echocardiography. Circulation 63: 409–418PubMedCrossRefGoogle Scholar
  14. 13.
    Yamaguchi H, Ishimura T, Nishiyanna S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K (1979) Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44: 401–412PubMedCrossRefGoogle Scholar
  15. 14.
    Maron BJ, Clark CE, Henry WL, Fukuda T, Edwards JE, Mathews EC, Redwood DR, Epstein SE (1977) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart disease: echocardiographic and morphologic findings. Circulation 55: 489–496PubMedGoogle Scholar
  16. 15.
    Maron BJ, Edwards JE, Epstein SE (1978) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with systemic hypertension. Chest 73: 466–470PubMedCrossRefGoogle Scholar
  17. 16.
    Maron BJ, Savage DD, Clark CE, Henry WL, Vlodaver Z, Edwards JE, Epstein SE (1978) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with coronary artery disease. Circulation 57: 250–255PubMedGoogle Scholar
  18. 17.
    Maron BJ, Edwards JE, Ferrans VJ, Clark CE, Lebowitz EA, Henry WL, Epstein SE (1975) Congenital heart malformations associated with disproportionate ventricular septal thickening. Circulation 52: 926–932PubMedGoogle Scholar
  19. 18.
    Paré JA, Fraser RG, Pirozynski WJ, Shanks JA, Stubington D (1961) Hereditary cardiovascular dysplasia: A form of familial cardiomyopathy. Am J Med 31: 37–62PubMedCrossRefGoogle Scholar
  20. 19.
    Ferrans VJ, Morrow AG, Roberts WC (1972) Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation 45: 769–792PubMedGoogle Scholar
  21. 20.
    Maron BJ, Ferrans VJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Morrow AG, Epstein SE (1974) Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light and electron microscopic findings. Circulation 50: 436–446PubMedGoogle Scholar
  22. 21.
    Maron BJ, Epstein SE, Roberts WC (1978) Cardiac muscle cell disorganization in the ventricular septum: Evidence from quantitative histology that it is a highly sensitive marker of hypertrophic cardiomyopathy ( Abstr ). Am J Cardiol 41: 435CrossRefGoogle Scholar
  23. 22.
    Maron BJ, Epstein SE (1980) Hypertrophic cardiomyopathy: Recent observations regarding the specificity of three hallmarks of the disease: ASH, Septal Disorganization and SAM. Am J Cardiol 45: 141–154PubMedCrossRefGoogle Scholar
  24. 23.
    Maron BJ, Anan TJ, Roberts WC (to be published) Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. CirculationGoogle Scholar
  25. 24.
    Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59: 689–706PubMedGoogle Scholar
  26. 25.
    Hardarson T, De La Calzada CS, Curiel R, Goodwin JF (1973) Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 2: 1462–1467PubMedCrossRefGoogle Scholar
  27. 26.
    Shah PM, Adelman AG, Wigle ED, Gobel FL, Burchell HB, Hardarson T, Curiel R, De La Calzada C, Oakley CM, Goodwin JF (1973) The natural (and unnatural) course of hypertrophic obstructive cardiomyopathy. A multicenter study. Circ Res (Suppl II) 24 and 25: 179–195Google Scholar
  28. 27.
    Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE (1976) Asymmetric septal hypertrophy in childhood. Circulation 52: 9–19Google Scholar
  29. 28.
    Maron BJ, Lipson LC, Roberts WC, Savage DS, Epstein SE (1978) “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 41: 1133–1140PubMedCrossRefGoogle Scholar
  30. 29.
    Maron BJ, Roberts WC, Edwards JE, McAllister HA, Foley DD, Epstein SE (1978) Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients without functional limitation. Am J Cardiol 41: 803–810PubMedCrossRefGoogle Scholar
  31. 29a.
    Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophic cardiomyopathy: profile of 78 patients. Circulation (in press)Google Scholar
  32. 30.
    Savage DD, Seides SF, Clark CE, Henry WL, Maron BJ, Robinson FC, Epstein SE (1978) Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58: 402–408PubMedGoogle Scholar
  33. 31.
    Ingham RE, Rossen RM, Goodman DJ, Harrison DC (1975) Ambulatory electrocardiographic monitoring in idiopathic hypertrophic subaortic stenosis ( Abstr ). Circulation (Suppl II) 52: 83Google Scholar
  34. 32.
    McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol 45: 1–5PubMedCrossRefGoogle Scholar
  35. 33.
    Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43: 1086–1102PubMedCrossRefGoogle Scholar
  36. 33a.
    Maron BJ, Savage DD, Wolfson JK, Epstein SE (1981) Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Amer J Cardiol 48: 252–257PubMedCrossRefGoogle Scholar
  37. 34.
    Goodwin JF, Oakley CM (1972) The cardiomyopathies. Br Heart J 34: 545–552PubMedCrossRefGoogle Scholar
  38. 35.
    Borer JS, Bacharach SL, Green MV, Kent KM, Maron BJ, Rosing DR, Seides SF, Epstein SE (1978) Obstructive vs nonobstructive asymmetric septal hypertrophy: differences in left ventricular function with exercise (Abstr) Am J Cardiol 41: 379Google Scholar
  39. 36.
    Steward S, Mason D, Braunwald E (1968) Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 37: 8–14Google Scholar
  40. 37.
    St John Sutton MG, Tajik AJ, Gibson DG, Brown DJ, Seward JB, Giuliani ER (1978) Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic subaortic stenosis. Circulation 57: 512–520Google Scholar
  41. 38.
    Hanrath P, Mathey DG, Siegert R, Bleifeld W (1980) Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: and echocardiographic study. Am J Cardiol 45: 15–23PubMedCrossRefGoogle Scholar
  42. 38a.
    Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE (1981) Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64: 787–796PubMedCrossRefGoogle Scholar
  43. 39.
    Cohen LS, Braunwald E (1967) Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation 35: 847–851PubMedGoogle Scholar
  44. 40.
    Hubner PJB, Ziady G, Lane GK, et al (1973) Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J 35: 1116–1123PubMedCrossRefGoogle Scholar
  45. 41.
    Morrow AG (1978) Hypertrophic subaortic stenosis: operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg 76: 423–430PubMedGoogle Scholar
  46. 42.
    Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG (1978) Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 57: 1205–1213PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • Stephen E. Epstein
  • Barry J. Maron

There are no affiliations available

Personalised recommendations